logo-loader

Full interview: THC Global receives final licences and will complete product validation by end of year

Published: 19:22 29 Oct 2019 EDT

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive on receiving the final licences required for Australian production and distribution of narcotic medicines, including medicinal cannabis, for the recently opened Southport and Bundaberg manufacturing facilities in Queensland.

The company will also complete product validation by the end of 2019 and expects to be supplying medicinal cannabis to Australian patients early in 2020.

In addition, the CEO updated the market about an increased presence for THC Global in New Zealand.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

5 hours, 16 minutes ago